Armenia faces shortage of blood-cancer drugs, says foundation rep

15:52 • 30.01.12

Armenia faces a shortage of unlicensed drugs that could be effective remedies for treating blood cancer, according to a representative of an Armenian foundation aiding children with leukemia.

At a news conference on Monday, Edgar Gyanjumyan, the head Ognem (Let me Help) foundation’s trusteeship board, said the drugs not officially registered in Armenia are being widely used abroad.

''We have applied to competent bodies, and I think the state can find a solution,'' he said. '' The second problem we raise is finding a shelter for the children suffering from the disease. Many of them are from regions and stay with their relatives in Yerevan. Is that really convenient?''

Another problem, according to Gyanjumyan, is the possibility that the children who return to the regions after receiving treatment may catch infections in transport.

''They are very weak and sensitive to any infection that can affect their treatment, '' he added.

He said further that the state allocations are not often enough to cover medical costs, as newer and newer methods of treatment are being invented.

''But doctors are compassionate and eager to use the newest methods to treat [the children]. So in such cases, different foundations often render assistance, '' he said.

Gyanjumyan added that Armenia 's first lady, Rita Sargsyan, who is the head of the Donate Life foundation’s trusteeship board, has a personal involvement in assisting children with blood cancer.